By


Ride Health Raises $6.2 Million to Coordinate the Medical Transportation Ecosystem
Company delivers first real-time ride coordination platform to improve access to care and patients’ ride experience  

See more here

By


Relmada Therapeutics Strengthens Board of Directors with Appointment of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool

See more here

By


iView Announces First Patient Treated in Phase 2 Clinical Trial Program Evaluating IVIEW-1201 in Patients with Acute Adenoviral Conjunctivitis

See more here

By


Relmada Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

See more here

By


Harvard Pilgrim Health Care And Ride Health Collaborate To Provide Health Care-Related Transportation For Medicare Members In Two States

See more here

By


CARB-X funds VenatoRx Pharmaceuticals to support the development of a new class of oral antibiotics to treat multi-drug-resistant gonorrhea
Funding represents 51st CARB-X Award, and 2nd CARB-X Award for VenatoRx 

See more here

By


Palvella Therapeutics Commences Phase 3 Portion of Phase 2/3 Pivotal Study of PTX-022 in Pachyonychia Congenita
Fast Track-designated program aims to be first targeted therapy addressing root cause of chronically debilitating rare genetic disease 

See more here

By


Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients
– Strategic collaboration may support future trials with CAR T-cell therapy 
– Tmunity will use Oncora Medical’s proprietary analytical tools to access real world data and innovate clinical trial design

See more here